Ovarian Cancer Trial, Recruiting (NCT06155708)

Ovarian Cancer Trial, Recruiting NCT06155708 Sponsor: McGill University Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06155708 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You were assigned female at birth
You are between 18 and 40 years old
You have been diagnosed with Polycystic Ovary Syndrome (PCOS)

Who may not be able to join:

You currently smoke or have a long history of smoking in the past
You have or have previously had a serious heart or metabolic condition (such as high blood pressure stage 2, diabetes, or heart disease), a neurological condition, or a hormonal disorder (other than PCOS)
You are currently pregnant or breastfeeding
You are currently taking certain medications that could affect the study results, such as blood pressure medications, hormone-related medications, or metformin (confirm with trial site for a full list)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Charlotte Usselman, Ph.D, McGill University

Phone: 5143962140

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06155708

Sponsor: McGill University

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: 5143962140

More information: https://clinicaltrials.gov/study/NCT06155708

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You were assigned female at birth
You are between 18 and 40 years old
You have been diagnosed with Polycystic Ovary Syndrome (PCOS)

Who may not be able to join:

You currently smoke or have a long history of smoking in the past
You have or have previously had a serious heart or metabolic condition (such as high blood pressure stage 2, diabetes, or heart disease), a neurological condition, or a hormonal disorder (other than PCOS)
You are currently pregnant or breastfeeding
You are currently taking certain medications that could affect the study results, such as blood pressure medications, hormone-related medications, or metformin (confirm with trial site for a full list)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

McGill University

Registry

ClinicalTrials.gov

Start date

20 January 2025

Est. completion

1 June 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Glycemic responses to a 2-hr oral glucose tolerance test; Flow mediated dilation (FMD); Systolic Blood Pressure (SBP); Diastolic Blood Pressure (DBP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov